why choose us

First received: September 22, 2022

Clinical Trial: Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adherence, Patient

Study Type: INTERVENTIONAL


Official Title: Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM in Normal Humans

Brief Summary: This is a pilot study for identifying plasma and/or urine-derived adherence/surrogate biomarker candidates for verifying Immulina™ ingestion by human volunteers (collected before and after consumption of Immulina™, a natural dietary supplement).

Read more